Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1979 Feb;9(2):186–188. doi: 10.1128/jcm.9.2.186-188.1979

Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.

E Holten
PMCID: PMC272987  PMID: 107188

Abstract

During the first 6 months of 1978, 114 strains of Neisseria meningitidis isolated from patients in Norway were serotyped. Among 27 group C strains, type 2 was most common, whereas 82% of the 82 group B isolates did not react with antisera to the standard serotypes 1 to 12. These strains were shown to belong to a new serotype, type 15. Also some group A and C strains had the type 15 antigen. Investigations on a possible immunoprophylaxis against group B meningococcal disease in Norway should accordingly proceed with type 15 rather than with type 2 meningococci.

Full text

PDF
186

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bovre K., Holten E., Vik-Mo H., Brondbo A., Bratlid D., Bjark P., Moe P. J. Neisseria meningitidis infections in Northern Norway: an epidemic in 1974-1975 due mainly to group B organisms. J Infect Dis. 1977 Apr;135(4):669–672. doi: 10.1093/infdis/135.4.669. [DOI] [PubMed] [Google Scholar]
  2. Farries J. S., Dickson W., Greenwood E., Malhotra T. R., Abbott J. D., Jones D. M. Meningococcal infections in Bolton, 1971-74. Lancet. 1975 Jul 19;2(7925):118–120. doi: 10.1016/s0140-6736(75)90016-1. [DOI] [PubMed] [Google Scholar]
  3. Frasch C. E., Chapman S. S. Classification of Neisseria meningitidis group B into distinct serotypes. 3. Application of a new bactericidal-inhibition technique to distribution of serotypes among cases and carriers. J Infect Dis. 1973 Feb;127(2):149–154. doi: 10.1093/infdis/127.2.149. [DOI] [PubMed] [Google Scholar]
  4. Frasch C. E., Chapman S. S. Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method. Infect Immun. 1972 Jan;5(1):98–102. doi: 10.1128/iai.5.1.98-102.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Frasch C. E., Chapman S. S. Classification of Neisseria meningitidis group B into distinct serotypes. II. Extraction of type-specific antigens for serotyping by precipitin techniques. Infect Immun. 1972 Aug;6(2):127–133. doi: 10.1128/iai.6.2.127-133.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Frasch C. E., Gotschlich E. C. An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity. J Exp Med. 1974 Jul 1;140(1):87–104. doi: 10.1084/jem.140.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frasch C. E., Robbins J. D. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. J Exp Med. 1978 Mar 1;147(3):629–644. doi: 10.1084/jem.147.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Frasch C. E. Role of protein serotype antigens in protection against disease due to Neisseria meningitidis. J Infect Dis. 1977 Aug;136 (Suppl):S84–S90. doi: 10.1093/infdis/136.supplement.s84. [DOI] [PubMed] [Google Scholar]
  9. Gold R., Winklehake J. L., Mars R. S., Artenstein M. S. Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping. J Infect Dis. 1971 Dec;124(6):593–597. doi: 10.1093/infdis/124.6.593. [DOI] [PubMed] [Google Scholar]
  10. Gold R., Wyle F. A. New Classification of Neisseria meningitidis by Means of Bactericidal Reactions. Infect Immun. 1970 May;1(5):479–484. doi: 10.1128/iai.1.5.479-484.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Holten E., Bratlid D., Bøvre K. Carriage of Neisseria meningitidis in a semi-isolated arctic community. Scand J Infect Dis. 1978;10(1):36–40. doi: 10.3109/inf.1978.10.issue-1.08. [DOI] [PubMed] [Google Scholar]
  12. Holten E., Vaage L. Carriers of meningococci among Norwegian naval recruits. Scand J Infect Dis. 1971;3(2):135–140. doi: 10.3109/inf.1971.3.issue-2.07. [DOI] [PubMed] [Google Scholar]
  13. Holten E., Vaage L., Neess C., Midtvedt T., Jyssum K. Sulphonamide-resistant meningococci after sulphonamide prophylaxis among vaval recruits in Norway. Scand J Infect Dis. 1969;1(3):185–189. [PubMed] [Google Scholar]
  14. Munford R. S., Patton C. M., Gorman G. W. Epidemiologic studies of serotype antigens common to groups B and C Neisseria meningitidis. J Infect Dis. 1975 Mar;131(3):286–290. doi: 10.1093/infdis/131.3.286. [DOI] [PubMed] [Google Scholar]
  15. Wyle F. A., Artenstein M. S., Brandt B. L., Tramont E. C., Kasper D. L., Altieri P. L., Berman S. L., Lowenthal J. P. Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis. 1972 Nov;126(5):514–521. doi: 10.1093/infdis/126.5.514. [DOI] [PubMed] [Google Scholar]
  16. Zollinger W. D., Mandrell R. E., Altieri P., Berman S., Lowenthal J., Artenstein M. S. Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. J Infect Dis. 1978 Jun;137(6):728–739. doi: 10.1093/infdis/137.6.728. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES